ENA

23 października 2024

AACR-NCI-EORTC International Conference (ENA) 2024, October 23-25, 2024

Rok

2024

Cel

RVU120 (CDK8/CDK19), RVU 305 (PRMT5), ONCO Prime, Novel Targets, WRN

Zasoby na tej stronie

Pobierz zasoby

  • plik pdf

    Phase I/II trial of RVU120, a CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors

    Pobierz
  • plik pdf

    Discovery of novel MTA-cooperative PRMT5 preclinical candidate as targeted therapeutics for MTAP-deleted cancers

    Pobierz
  • plik pdf

    Discovery of WRN inhibitors as targeted therapy in the treatment of microsatellite unstable (MSI-H) tumors

    Pobierz
  • plik pdf

    Exploring Synthetic Lethality and Novel Drug Combinations in Patient-Derived Cells

    Pobierz